MiMedx Group, Inc. (MDXG) Wins Ruling Vacating FDA AXIOFILL Decisions

A U.S. District Court vacated FDA determinations that AXIOFILL is not minimally manipulated and should be a biological product, and remanded the matter to FDA for reconsideration consistent with the order.Material DetailsContext by AI AnalystThis is a mid-cycle legal-development that could ease reg…